NPA Responds as Durbin-Braun Proposal for Dietary Supplements Makes Its Way into PDUFA

On May 17, the United States Senate Health, Education, Labor, and Pensions Committee (HELP) released a discussion draft of its legislation to reauthorize FDA user fees for drugs, biologics and medical devices package, which includes the controversial and divisive Durbin-Braun premarket approval concept and more that would be damaging to the industry, according to the ...